Translating Epigenetic Alterations in Leukemia into Biomarkers of the Disease and for Target Therapies with DNA Demethylating DrugsFriday, 7 June 2013 at 11:00 Add to Calendar ▼2013-06-07 11:00:002013-06-07 12:00:00Europe/LondonTranslating Epigenetic Alterations in Leukemia into Biomarkers of the Disease and for Target Therapies with DNA Demethylating DrugsTranslational Medicine Summit in HamburgHamburgSELECTBIOenquiries@selectbiosciences.com Aberrant DNA methylation patterns are a common hallmark of tumor cells. We will discuss the translational potential of these epimutations as cancer biomarkers and possible therapeutic strategies related to DNA demethylation. |